| Contributors |
|
xi | |
| Preface |
|
xv | |
|
1 Utility of bacterial peptidoglycan recycling enzymes in the chemoenzymatic synthesis of valuable UDP sugar substrates |
|
|
1 | (26) |
|
|
|
|
|
|
|
|
|
|
|
Catherine Leimkuhler Grimes |
|
|
|
|
2 | (4) |
|
|
|
6 | (16) |
|
|
|
22 | (1) |
|
|
|
22 | (1) |
|
|
|
23 | (4) |
|
2 Chemical tools for selective activity profiling of bacterial penicillin-binding proteins |
|
|
27 | (30) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28 | (2) |
|
2 Activity-based profiling of penicillin-binding proteins |
|
|
30 | (12) |
|
3 Gel-based analysis of PBP activity profile |
|
|
42 | (4) |
|
4 In vivo imaging of PBP activity |
|
|
46 | (4) |
|
5 Additional considerations and controls |
|
|
50 | (1) |
|
|
|
51 | (1) |
|
|
|
52 | (1) |
|
|
|
52 | (5) |
|
3 Fluorescent stem peptide mimics: In situ probes for peptidoglycan crosslinking |
|
|
57 | (12) |
|
|
|
|
|
|
|
|
|
|
|
58 | (2) |
|
|
|
60 | (2) |
|
3 Bacterial growth and FSPM labeling |
|
|
62 | (1) |
|
4 Quantification of crosslinking by flow cytometry |
|
|
63 | (1) |
|
5 Localization of crosslinking by microscopy |
|
|
64 | (1) |
|
|
|
65 | (1) |
|
|
|
66 | (3) |
|
4 Gram-scale preparation of the antibiotic lead compound salicyl-AMS, a potent inhibitor of bacterial salicylate adenylation enzymes |
|
|
69 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 | (2) |
|
2 Synthesis of salicyl-AMS, sodium salt |
|
|
72 | (4) |
|
|
|
76 | (7) |
|
|
|
83 | (1) |
|
|
|
84 | (1) |
|
|
|
84 | (1) |
|
|
|
84 | (5) |
|
5 Probe-enabled approaches for function-dependent cell sorting and characterization of microbiome subpopulations |
|
|
89 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
90 | (2) |
|
2 Probe design for FACS-enabled isolation |
|
|
92 | (4) |
|
3 Labeling and selectivity protocols |
|
|
96 | (3) |
|
4 Microbiome sample preparation |
|
|
99 | (2) |
|
5 Fluorescence-activated cell sorting (FACS) protocols |
|
|
101 | (3) |
|
|
|
104 | (1) |
|
|
|
104 | (1) |
|
|
|
104 | (5) |
|
6 Biochemical analysis of NlpC/p60 peptidoglycan hydrolase activity |
|
|
109 | (20) |
|
|
|
|
|
|
|
|
|
110 | (1) |
|
2 Bacterial expression and purification of recombinant NlpC/p60 proteins |
|
|
111 | (5) |
|
3 Large scale isolation of peptidoglycan |
|
|
116 | (3) |
|
4 Biochemical analysis of NlpC/p60 peptidoglycan hydrolase activity |
|
|
119 | (6) |
|
5 Summary and conclusions |
|
|
125 | (1) |
|
|
|
125 | (1) |
|
Conflict of interest statement |
|
|
125 | (1) |
|
|
|
126 | (3) |
|
7 Controlled release of bioactive signaling molecules |
|
|
129 | (10) |
|
|
|
|
|
|
|
|
|
130 | (1) |
|
|
|
131 | (6) |
|
|
|
137 | (1) |
|
|
|
138 | (1) |
|
|
|
138 | (1) |
|
8 Imaging nascent transcription in wholemount vertebrate embryos to characterize zygotic genome activation |
|
|
139 | (28) |
|
|
|
|
|
|
|
140 | (2) |
|
|
|
142 | (18) |
|
|
|
160 | (1) |
|
|
|
161 | (2) |
|
|
|
163 | (1) |
|
|
|
163 | (4) |
|
9 Engineering reversible cell-cell interactions with chemical biology |
|
|
167 | (24) |
|
|
|
|
|
|
|
168 | (1) |
|
2 Nongenetic approaches to engineering cell-cell interactions |
|
|
169 | (7) |
|
3 Engineering reversible cell-cell interactions with chemically self-assembled nanorings (CSANS) |
|
|
176 | (2) |
|
|
|
178 | (6) |
|
5 Analysis of the cell-cell interactions |
|
|
184 | (3) |
|
|
|
187 | (1) |
|
|
|
187 | (1) |
|
|
|
188 | (3) |
|
10 Fast phosphine-activated control of protein function using unnatural lysine analogues |
|
|
191 | (28) |
|
|
|
|
|
|
|
192 | (4) |
|
|
|
196 | (15) |
|
3 Controlling protein SUMOylation with phosphine triggers |
|
|
211 | (3) |
|
|
|
214 | (1) |
|
|
|
214 | (1) |
|
|
|
214 | (5) |
|
11 Photopharmacological control of lipid function |
|
|
219 | (14) |
|
|
|
|
|
|
|
219 | (1) |
|
2 General consideration when working with azobenzene-photoswitches |
|
|
220 | (5) |
|
3 Photopharmacological assay methods--Exemplified with PhotoSIP |
|
|
225 | (6) |
|
|
|
231 | (1) |
|
|
|
231 | (2) |
|
12 Expanding the substrate selectivity of SNAP/CLIP-tagging of intracellular targets |
|
|
233 | (26) |
|
|
|
|
|
|
|
|
|
234 | (2) |
|
|
|
236 | (1) |
|
3 SNAP-tag labeling of an (O6-(5-pyridy I methyl) guanine substrate |
|
|
237 | (7) |
|
4 Two-step bioorthogonal labeling |
|
|
244 | (9) |
|
|
|
253 | (1) |
|
|
|
254 | (1) |
|
|
|
254 | (5) |
|
13 Light-induced protein proximity by activation of gibberellic acid derivatives in living cells |
|
|
259 | (14) |
|
|
|
|
|
|
|
260 | (5) |
|
|
|
265 | (5) |
|
|
|
270 | (1) |
|
|
|
270 | (1) |
|
|
|
270 | (3) |
|
14 Photoactivatable trimethoprim-based probes for spatiotemporal control of biological processes |
|
|
273 | (22) |
|
|
|
|
|
|
|
|
|
274 | (4) |
|
2 Preparation and synthesis |
|
|
278 | (7) |
|
|
|
285 | (3) |
|
|
|
288 | (4) |
|
|
|
292 | (1) |
|
6 Summary and Conclusions |
|
|
292 | (1) |
|
|
|
293 | (1) |
|
|
|
293 | (2) |
|
15 Site-specific antibody fragment conjugates for targeted imaging |
|
|
295 | (26) |
|
|
|
|
|
|
|
|
|
|
|
296 | (3) |
|
2 Genetic incorporation of UAA to fab fragments |
|
|
299 | (5) |
|
3 Linker compound synthesis |
|
|
304 | (3) |
|
4 Site-specific fab conjugation and purification |
|
|
307 | (2) |
|
5 In vitro characterization of the fab conjugates |
|
|
309 | (5) |
|
6 In vivo imaging using fab conjugates |
|
|
314 | (4) |
|
7 Summary and conclusions |
|
|
318 | (3) |
|
|
|
318 | (1) |
|
|
|
318 | (3) |
|
16 Quantifying protein-protein interactions of the acyl carrier protein with solvatochromic probes |
|
|
321 | |
|
|
|
|
|
|
|
322 | (2) |
|
2 Preparation of 4-DMN-EcACP |
|
|
324 | (12) |
|
3 Protein-protein interaction studies using 4-DMN-EcACP |
|
|
336 | (3) |
|
4 Summary and conclusions |
|
|
339 | |
|
|
|
340 | (1) |
|
|
|
340 | |
